Approval · Notice of Compliance 37035 · 2026
BALANSYA: Notice of Compliance 37035
Issued March 4, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 37035
- Date
- March 4, 2026
- Company
- Orimed Pharma Inc.Boucherville, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BALANSYA | 02566354 | Marketed |
Medicinal ingredients
- ESCITALOPRAM OXALATE 2 MG per ML